Why is Czechia a key player in our CEE network❓ 📋 EU High Enroller – joined the EU in 2004⏱️ Regulatory pathway aligned with EU/EMA
Once all essential preclinical and clinical data have been gathered, the next critical phase is compiling the Clinical Evaluation Report (CER). This is the culmination
A recently published study introduces the PIPEDREAM model, using aggregated historical data from the pharmaceutical industry between 1997 and 2007. It highlights just how challenging
At BiTrial, we recognize the importance of maintaining the highest standards in clinical research and product development, that includes a deep understanding of FDA inspections.
In our series on the life path of medical devices, today we’re discussing the critical phase of conducting clinical trials. This step is essential to
Here are some key factors that make Serbia an essential part of our clinical research network: 📍 Strategic location: While Serbia is not an EU
The latest article from Applied Clinical Trials addresses a key issue in drug development: how to close the gap between controlled clinical trial results and
This phase is vital for ensuring that all clinical aspects of the device are thoroughly evaluated and documented. 📋 Here are the key elements of
In our series showcasing BiTrial’s international presence, we highlight the dynamic research landscape and the key role Moldova plays in our global strategy. ✅EU candidate
Regulatory expertise for MD studies 🚀 ✅ Risk classification – We assess your device’s classification based on its intended use, technology, and patient impact, determining
